帕金森病的依赖阶段的蛋白酶重塑 血细胞 血细胞
Giorgia Massacci1, Veronica Venafra2, Maximilian Zwiebel3
1Department of Biology, University of Rome Tor Vergata, Rome, Italy.
Neurobiology of disease
|August 3, 2024
概括
这项研究使用了来自帕金森病 (PD) 患者的血细胞上的基蛋白质,以发现疾病进展的分子迹象. 这些发现揭示了特定阶段的模式,可以提高对PD异质性的理解.
科学领域:
- 神经科学是一个神经科学.
- 蛋白质组学是指蛋白质组学.
- 生物化学 生物化学
背景情况:
- 帕金森病 (PD) 是复杂而异质的,需要更好的诊断和预后工具.
- 了解PD的分子机制对于有效的治疗开发至关重要.
研究的目的:
- 在异常性PD患者中对外围血液单核细胞 (PBMCs) 进行试点基蛋白质分析.
- 为了确定功能性改变和关键分子/参与PD进展的途径.
- 为了发现PD的特定阶段的分子特征.
主要方法:
- 从不同疾病阶段的异常性PD患者中对PBMC的试验光蛋白质分析.
- 整合临床数据与基蛋白质蛋白质样本.
- 在PD进展过程中对功能变化和分子特征的分析.
主要成果:
- 在PD患者中识别潜在的特定阶段的分子特征.
- 在PD过程中对PBMCs的功能性改变的划定.
- 通过综合性分析增强对PD异质性的理解.
结论:
- 对PBMC的基蛋白质分析可以揭示PD中特定阶段的分子特征.
- 这种方法有助于理解PD的进展和异质性.
- 对改善帕金森病的诊断和预后工具的潜力.
更多相关视频
相关概念视频
Parkinson's Disease: Overview
508
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
508
Parkinson's Disease: Treatment
241
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
241
Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
Protein Kinases and Phosphatases
13.1K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.1K


